Renaissance Capital logo

MOBI News

US IPO Weekly Recap: Space intelligence provider HawkEye 350 leads 5 IPO week as pipeline grows

HAWK

Five IPOs and three SPACs priced this week. Five IPO and two SPACs submitted filings. Signal processing platform HawkEye 360 (HAWK) priced at the top of the range to raise $416 million at a $2.8 billion market cap. HawkEye 360 is a defense technology...read more

Nerve stimulation device maker Mobia Medical prices IPO at $15, the midpoint of the range

Mobia Medical logo

Mobia Medical, which sells a nerve stimulation implant for chronic ischemic stroke, raised $150 million by offering 10 million shares at $15, within the $14 to $16 range. At pricing, the company commands a fully diluted market value of $549 million. Mobia's...read more

Nerve stimulation device maker Mobia Medical sets terms for $150 million IPO, pricing this week

Mobia Medical logo

Mobia Medical, which sells a nerve stimulation device for chronic ischemic stroke, announced terms for its IPO on Monday. The Austin, TX-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. Mobia's Vivistim...read more

US IPO Week Ahead: May IPO market kicks off with defense tech, soft drinks, and more

HAWK

Updated Monday, 5/4. Five IPOs are currently scheduled for the week ahead, though some smaller names may join the calendar late. Radio signal analyzer HawkEye 360 (HAWK) plans to raise $400 million at a $2.7 billion market cap. HawkEye designs and operates...read more